Bank Of America Corp Apellis Pharmaceuticals, Inc. Transaction History

Bank Of America Corp

$1.43 Trillion
Q3 2025

A detailed history of Bank Of America Corp transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 1,477,525 shares of APLS stock, worth $30 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,477,525

Previous 2,426,628 39.11%

Holding current value

$30 Million

Previous $42 Million 20.4%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$17.42 - $28.65 $16.5 Million - $27.2 Million	-949,103 Reduced 39.11%	1,477,525 $33.4 Million
Q2 2025 Aug 14, 2025	SELL	$16.36 - $23.0 $11.5 Million - $16.2 Million	-704,808 Reduced 22.51%	2,426,628 $42 Million
Q1 2025 May 15, 2025	BUY	$21.87 - $34.63 $31.7 Million - $50.3 Million	1,451,223 Added 86.37%	3,131,436 $68.5 Million
Q4 2024 Feb 14, 2025	BUY	$26.18 - $35.42 $18.5 Million - $25 Million	705,209 Added 72.33%	1,680,213 $53.6 Million
Q3 2024 Nov 14, 2024	SELL	$28.84 - $41.15 $578,674 - $825,674	-20,065 Reduced 2.02%	975,004 $28.1 Million

Q2 2024 Aug 14, 2024	BUY	$38.07 - $59.71 $10.3 Million - $16.2 Million	271,625 Added 37.55%	995,069 $38.2 Million
Q1 2024 May 15, 2024	BUY	$55.39 - $72.47 $16 Million - $21 Million	289,107 Added 66.56%	723,444 $42.5 Million
Q4 2023 Feb 14, 2024	BUY	$37.14 - $64.82 $909,744 - $1.59 Million	24,495 Added 5.98%	434,337 $26 Million
Q2 2023 Aug 14, 2023	SELL	$76.68 - $93.31 $15.2 Million - $18.5 Million	-197,893 Reduced 32.56%	409,842 $37.3 Million
Q1 2023 May 12, 2023	BUY	$46.59 - $66.96 $6.46 Million - $9.29 Million	138,723 Added 29.58%	607,735 $40.1 Million
Q4 2022 Feb 10, 2023	SELL	$43.24 - $61.04 $9.64 Million - $13.6 Million	-222,865 Reduced 32.21%	469,012 $24.3 Million
Q3 2022 Nov 14, 2022	BUY	$44.76 - $69.66 $14.5 Million - $22.5 Million	323,561 Added 87.85%	691,877 $47.3 Million
Q2 2022 Aug 12, 2022	SELL	$35.07 - $59.21 $478,424 - $807,742	-13,642 Reduced 3.57%	368,316 $16.7 Million
Q1 2022 May 16, 2022	BUY	$35.46 - $54.12 $3.8 Million - $5.79 Million	107,052 Added 38.94%	381,958 $19.4 Million
Q4 2021 Feb 08, 2022	SELL	$30.74 - $49.16 $155,728 - $249,044	-5,066 Reduced 1.81%	274,906 $13 Million
Q3 2021 Nov 15, 2021	BUY	$31.4 - $69.84 $1.24 Million - $2.77 Million	39,593 Added 16.47%	279,972 $9.23 Million
Q2 2021 Sep 13, 2021	BUY	$40.9 - $64.9 $9.83 Million - $15.6 Million	240,379 New	240,379 $15.2 Million

Others Institutions Holding APLS

# of Institutions

328

Shares Held

124M

Call Options Held

4.12M

Put Options Held

756K

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $2.23B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Apellis Pharmaceuticals, Inc. Transaction History